Klaudia Blicharz

发表

A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties.

A. Bojarski, P. Marin, Rafał Kurczab, 2020, European journal of medicinal chemistry.

Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines.

T. Karcz, A. Bojarski, Rafał Kurczab, 2022, European journal of medicinal chemistry.

Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States.

A. Bojarski, P. Marin, Rafał Kurczab, 2021, Journal of Medicinal Chemistry.